Hernia Mesh Implant Lawsuit: Current Status by Manufacturer

What Hernia Mesh Lawsuits Allege

Hernia mesh is a surgical implant used to reinforce weakened tissue during hernia repair surgery, made from synthetic or biologic materials. Lawsuits against several major manufacturers allege that specific mesh products were defectively designed and prone to complications including adhesion to internal organs, bowel obstruction, chronic pain, infection, and mesh migration or shrinkage, often requiring painful revision surgery to remove or replace the device, and that manufacturers failed to adequately warn surgeons and patients about these risks.

This is a distinct category of medical device litigation from vaginal or pelvic mesh, which involves different products used for a different medical purpose, pelvic organ prolapse and urinary incontinence repair, implanted through a different surgical approach. The two should not be confused, since eligibility and the applicable litigation depend on the specific device and procedure involved.

Four Manufacturers, Four Very Different Stages

The litigation is organized into four separate federal multidistrict litigations, one per manufacturer, and each is at a meaningfully different stage as of mid-2026. The Bard, or C.R. Bard and Davol, MDL 2846 in the Southern District of Ohio is the largest, with roughly 23,700 cases pending. Bard parent company, Becton Dickinson, announced a master settlement agreement in October 2024 covering the vast majority of claims, and a qualified settlement fund with appointed special masters is now actively processing payments, though new cases continue to be filed and transferred into the MDL even as the settlement moves forward.

The Covidien, now Medtronic, MDL 3029 in the District of Massachusetts, with roughly 2,200 pending cases, has not reached a settlement and is instead heading toward its first bellwether trial, with jury selection scheduled for February 2026 in a case alleging the Symbotex mesh caused severe adhesions and a bowel obstruction. The Atrium C-Qur MDL 2753 in the District of New Hampshire is smaller, with roughly 300 cases, and has a court-approved settlement fund in place. The Ethicon, a Johnson and Johnson subsidiary, MDL 2782 in the Northern District of Georgia has largely wound down, with nearly all of its several thousand original claims resolved through settlements over time.

What This Means for a Potential Claim

Because these four litigations are at such different points, from an active, paying settlement fund to a pending bellwether trial, the practical value and process for a claim depends heavily on which specific manufacturer and product is involved. Someone with a Bard product may be entering an established payment process, while someone with a Covidien product is still in active pretrial litigation with outcomes less certain until the bellwether trials play out.

New claims continue to be filed across all four manufacturers even as some settlements proceed, and general eligibility typically requires the mesh to have been implanted on a specific date range and the patient to have experienced a qualifying complication, often including a revision surgery. Given how much the details vary by manufacturer, an individual case evaluation identifying the specific device is the necessary first step before assuming which process, if any, applies.

How to Get Legal Help

Identifying your specific hernia mesh brand and model, generally found in your surgical records or a device card, is the essential first step, since eligibility, litigation stage, and settlement status differ substantially between Bard, Covidien, Atrium, and Ethicon products. An attorney experienced in this litigation can confirm your specific device against the current status of each manufacturer MDL.

To follow any further developments, bookmark this page and subscribe to LawsuitWatch alerts.